Abstract
Background: Histologic liver biopsy is traditionally obtained by either a surgical, transvascular or percutaneous route. The utility of both EUS-FNA of the liver and EUS-guided Tru-Cut Biopsy (EUS-TCB) for extra-hepatic indications are established but the use EUS-TCB for known or suspected benign liver disease has not been described. Aim: To report our initial experience with EUS-TCB for known or suspected benign liver disease. Methods: Prospectively, outpatients with or without known chronic liver disease referred for routine upper EUS at our hospital were assessed for any potential benefit from simultaneous TCB of the liver.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
